- Home
- ASTH vs CLVT Comparison
ASTH vs CLVT Comparison
Compare ASTH & CLVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ASTH | CLVT |
|---|---|---|
| Founded | 1994 | 2016 |
| Country | United States | United Kingdom |
| Employees | 3000 | 12000 |
| Industry | Professional Services | EDP Services |
| Sector | Consumer Discretionary | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.7B |
| IPO Year | 2015 | N/A |
Fundamental Metrics
Financial Performance| Metric | ASTH | CLVT |
|---|---|---|
| Price | $27.65 | $2.17 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 6 | 7 |
| Target Price | ★ $34.00 | $3.22 |
| AVG Volume (30 Days) | 348.0K | ★ 5.3M |
| Earning Date | 05-07-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.46 | N/A |
| Revenue | ★ $519,907,752.00 | N/A |
| Revenue This Year | $27.32 | N/A |
| Revenue Next Year | $10.84 | $2.12 |
| P/E Ratio | $61.39 | ★ N/A |
| Revenue Growth | ★ 45.90 | N/A |
| 52 Week Low | $18.08 | $1.66 |
| 52 Week High | $34.80 | $4.77 |
Technical Indicators
Market Signals| Indicator | ASTH | CLVT |
|---|---|---|
| Relative Strength Index (RSI) | 66.44 | 35.60 |
| Support Level | $26.03 | $1.66 |
| Resistance Level | $29.04 | $3.85 |
| Average True Range (ATR) | 1.16 | 0.16 |
| MACD | 0.33 | -0.04 |
| Stochastic Oscillator | 82.77 | 13.64 |
Price Performance
Historical ComparisonAbout ASTH Astrana Health Inc.
Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company's three reportable segments are Care Partners, Care Delivery, and Care Enablement. It generates the majority of its revenue from the Care Partners segment.
About CLVT Clarivate Plc
Clarivate is a data, information, and software workflow solutions company serving customers primarily in academia, government, law, life sciences, and healthcare. The company was formerly part of Thomson Reuters before being sold to private equity as an independent company in 2016. In 2019, Clarivate went public on the New York Stock Exchange. Around half of the company's revenue is generated in the Americas, while Europe, Middle East, and Africa account for around a quarter.